The ISPE Biotechnology Conference will provide a platform for all stakeholders of the pharmaceutical and biopharmaceutical value chain to present recent innovations and trends, and openly discuss practical challenges and solutions. The focus of the conference will be on the development and manufacturing of biotechnology products, such as mABs, vaccines, cell and gene therapy, Advanced Therapeutic Medicinal Products (ATMPs), and mRNA-based products. The event will explore the challenges of increasing productivity, process intensification, flexibility, and agility when it comes to mass production.

The conference will feature presentations on topics such as time to market, shortened submission approval times, product transfer, new concepts for control strategy, quality oversight, manufacturing, and logistics. Discussions will be presented and considered within the current regulatory framework, and the impact of the evolving regulatory environment and the need to ensure continued innovation and continuity of the supply chain will be integrated throughout the programme and panel discussions.

Sustainability, driven by the energy crisis, will be the primary focus of the event. Participants will have the opportunity to engage with industry leaders, regulators, and peers through networking events and the conference programme. The location of the event is TBD.